Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markman

Showing results (401-410 of 1,623) with videos related to

Pageof 163
Sort By:
Current Opinion in Oncology|October 1, 1992
Systemic therapy for gynecologic cancerM Markman
Cancer Investigation|January 1, 1995
The objective clinical scientist versus the advocate: a complex ethical and political dilemma facing cancer investigators and the publicM Markman
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
Supportive careM Markman
Cancer Investigation|January 1, 1994
When regulatory requirements conflict with ethical study design: the case of oral ondansetronM Markman
Gynecologic Oncology|June 1, 1994
Resetting the CA-125 range for a complete response to chemotherapy: why?M Markman
Current Oncology Reports|August 28, 2012
Abandoning "TAP" as treatment of metastatic endometrial cancer: a serious example of the consequences resulting from the failure to adequately define the question being addressed in a phase 3 trialMaurie Markman
Dental Economics - Oral Hygiene|May 1, 1974
Preventing laboratory snafusS Markman
Current Oncology Reports|February 19, 2005
Care of pediatric cancers in the developing world: should this be a societal priority?Maurie Markman
Current Oncology Reports|December 22, 2004
'Flat-fixed dosing' of chemotherapy: a concept whose time has come?Maurie Markman
Journal of Cancer Research and Clinical Oncology|August 10, 2004
Chemotherapeutic management of recurrent/metastatic uterine carcinosarcomas (malignant mixed mullerian tumors): time for a re-appraisal?Maurie Markman
Pageof 163

Showing results (401-410 of 1,623) with videos related to

Sort By:
Pageof 163
Current Opinion in Oncology|October 1, 1992
Systemic therapy for gynecologic cancerM Markman
Cancer Investigation|January 1, 1995
The objective clinical scientist versus the advocate: a complex ethical and political dilemma facing cancer investigators and the publicM Markman
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
Supportive careM Markman
Cancer Investigation|January 1, 1994
When regulatory requirements conflict with ethical study design: the case of oral ondansetronM Markman
Gynecologic Oncology|June 1, 1994
Resetting the CA-125 range for a complete response to chemotherapy: why?M Markman
Current Oncology Reports|August 28, 2012
Abandoning "TAP" as treatment of metastatic endometrial cancer: a serious example of the consequences resulting from the failure to adequately define the question being addressed in a phase 3 trialMaurie Markman
Dental Economics - Oral Hygiene|May 1, 1974
Preventing laboratory snafusS Markman
Current Oncology Reports|February 19, 2005
Care of pediatric cancers in the developing world: should this be a societal priority?Maurie Markman
Current Oncology Reports|December 22, 2004
'Flat-fixed dosing' of chemotherapy: a concept whose time has come?Maurie Markman
Journal of Cancer Research and Clinical Oncology|August 10, 2004
Chemotherapeutic management of recurrent/metastatic uterine carcinosarcomas (malignant mixed mullerian tumors): time for a re-appraisal?Maurie Markman
Pageof 163